Centrex geht ab, +30% WKN:541434

Volumen schon jetz 500000 an der OTC.
Kurs geht ab, mal sehen wo das heut noch endet!

Gruß

Zum Handelsschluss kackt die immer ab ;-))), aber macht nix, die steigt bald auf 20 Cent, wetten?

otc ist unberechenbar.
Ich hätte mal lieber Neomedia kaufen sollen. Die sind heute 300 % explodiert.
Morgen gehts bestimmt nochmal hoch

...auch nich abgekackt.
Mit +29% eröffnet und auch beendet.
Klar dazwischen gings auch mal bis über 50% aber gut, wir werden
sehen was heut von dem Volumen(über 2Mio) und dem Kursanstieg übrig
bleibt. Gut zu wissen, dass es bei der kleinsten Nachricht sofort
abgeht wie ne Rakete, obwohl die News
Centrex nur indirekt betreffen. Was passiert wenn Centrex Technologie
von der Regierung gesponsert wird oder wenn neue Erfolgsmeldungen
bei der weiteren Entwicklung der Technologie kommen?

schon mal unangenehm aufgefallen:

www.sec.gov/litigation/litreleases/lr17911.htm

"
The Complaint alleges further that from February 20, 2002, through July 15, 2002, Maxxon, Mabie, and Thomas R. Coughlin, Jr., Maxxon's Medical Advisor, issued materially false or misleading statements in press releases concerning the status of Maxxon's 510(k) application with the Food and Drug Administration ("FDA"), in which Maxxon sought to have the FDA approve a new version of its syringe.
"

Ansonsten drück ich allen die Daumen,

Ed

www.sec.gov/litigation/complaints/comp17911.htm

"
4. Mabie made at least $1,602,173.50 in ill-gotten gains by selling Maxxon shares from 1998 through 2002. He sold many of his shares in violation of the registration provisions of the federal securities laws. In 2002, Coughlin made at least $50,290 in ill-gotten gains, and Vincent made at least $29,526.93 in ill-gotten gains. Mabie, Coughlin, and Vincent sold these shares at prices that were inflated by the impact of the materially false or misleading statements, or omissions of material facts, that they made and/or caused Maxxon to make.

....

58. Between February 20, 2002, and July 15, 2002, Coughlin sold approximately 289,500 shares of Maxxon stock and realized profits of at least $50,290.

59. Between February 20, 2002, and July 15, 2002, Vincent sold approximately 162,500 shares of Maxxon stock and realized profits of at least $29,526.93.

60. Mabie, Coughlin and Vincent sold these shares at prices that were inflated by virtue of materially false or misleading statements, or omissions of material facts, that they caused Maxxon to make regarding the status of the FDA's approval of Maxxon's 510(k) application.
"


Das Engagement vom Herrn Coughlin bei MAXXON wird auf der centrex gar nicht so deutlich.

Sehr merkwürdig ;-)

Ed

...auf der centrex Webseite....  

In any case, the company is a total crap shoot for any investor. Anyone who buys CNEX knows that

Rechne mit richtig Power up ab über 0,10€.
Mfg

Der Kurs wird in Amiland gemacht und nicht hier.Stand da am Freitag schon. auf dem Kurs.

September 15, 2003 06:00 AM US Eastern Timezone

Centrex, Inc. Featured in Latest Issue of Biometric Watch

TULSA, Okla.--(BUSINESS WIRE)--Sept. 15, 2003--Centrex, Inc. (OTCBB:CNEX) today announced that it has recently been featured in an article in the September 2003 issue of Biometric Watch. The article discusses Centrex`s development agreement with Micronics, Inc. and the application of microfluidics technology to single molecule nucleic acid detection. Centrex had recently announced the signing of a development agreement with Redmond, Wash.-based Micronics, Inc. to design and develop disposable, multipurpose microfluidics lab cards that incorporate Centrex`s single molecule nucleic acid detection (" SMD" ) technology.
Biometric Watch is a primary independent biometric news source for thousands of subscribers worldwide from both the government and the private sectors. Biometric Watch is written in a direct, easy to understand manner minus all the " techno-speak" jargon sometimes associated with technology newsletters. If you are interested in keeping pace with all the advancements in the fascinating world of biometric technology, reading about new applications and keeping up to date on both successes and failures in the industry, Biometric Watch is your number one news source. As a truly independent voice, Biometric Watch accepts no advertising and has no connection with any technology vendors. For more information, visit: www.biometricwatch.com.

Centrex`s SMD technology has been exclusively licensed from Los Alamos National Laboratories and represents advantages over existing DNA and RNA detection methods as well as culture-based test methods. The technology eliminates the need for amplification of the target DNA, which reduces the possibility of false positive and negative test results -- common concerns identified with other test procedures. Centrex`s detection system is designed to be adaptable to the detection of a variety of bacterial or viral organisms by recognizing the unique DNA or RNA fingerprint of the organism.

Centrex plans to focus on the commercialization of a first product that provides a simultaneous multi-channel detection system that is compact, fully automated and capable of monitoring the presence of biological agents in air, food and water. Potential additional applications for the Centrex technology include bioterrorism and Homeland Security, food and water processing, blood supply screening, and general DNA/RNA testing.

Micronics, Inc. offers full service custom lab card development and integrated instrumentation on behalf of clients worldwide. Micronics has both an established microfluidics-based patent portfolio and extensive experience in providing essential " microplumbing" of fluids to on card micro-electrical-mechanical systems (MEMS) devices, sensors, adsorbents, lateral flow strips, reagents, and membranes. Micronics can also embed glass, silicon, and other features on card. Micronics provides lab card prototyping as well as commercial lab card production services. For additional information, visit www.micronics.net.

For more information, visit the Centrex website at www.centrexcorporation.com or contact Ron Wheet at 843-971-4848.

This press release contains certain forward-looking statements. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Forward-looking statements in this document should be evaluated together with the many uncertainties that affect our business. Those uncertainties are discussed in the Company`s SEC filings.

Contacts


Centrex, Inc., Tulsa
Ron Wheet, 843-971-4848

Nur weiter so.
Mfg

...buch! Wer nicht rein geht ist selber Schuld! Es kommt kauflust, interesse und Phantasie rein!

Centrex Inc.    ISIN: US15640E1038  
Skontroführer: Peter Koch Xchange Broker GmbH (1366)    WKN: 541434  
   
Best Bid
 Volumen Quote
 5000 Euro  0,086  

Kauf Orders
 Überhang Limit
 14.000  0,086  
 46.500  0,085  
 106.500  0,082  
 156.500  0,08  
 160.500  0,079  
Weitere: 13  
  Best Ask
Quote Volumen  
0,09  5000 Euro    

Verkauf Orders
Limit Überhang  
0,09  7.500    
0,098  13.500    
0,1  68.500    
0,101  83.500    
0,12  143.500    
Weitere: 3  
   
Letzter Preis  
Zeit: 10:00:30    
Preis: 0,088    
 
Tagesübersicht  
Kurse: 6    
Umsatz: 250.477    

 
Fragen zu Ihrer Order beantwortet gerne unsere Handelsüberwachungsstelle Telefon : 030 - 311091 - 45 / 71 / 73 / 76  
 
LiveHTML: running  

werde ich jetzt schnell mal auch mein Päckchen ins trockene bringen.

an alle die zu 0,06 Euro rein sind.

Gruß

kann komm ich auch noch mit , aber momentan bin ich an meine Calypte und anderen Werten gebunden - aber ich steig noch irgendwann ein !

Gruß leobmw

ich kann immernochnicht rein - haaaa - hoffentlich komm ich nicht zu spät !!

Mittwoch bin ich bei euch !!

noch nix neues zu Centrex?
Lohnt es sich, den Wert noch zu halten?